Form 8-K - Current report:
SEC Accession No. 0001213900-25-001392
Filing Date
2025-01-07
Accepted
2025-01-07 08:00:07
Documents
15
Period of Report
2025-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0226957-8k_cormedix.htm   iXBRL 8-K 30127
2 PRESS RELEASE ISSUED BY CORMEDIX INC., DATED JANUARY 7, 2025 ea022695701ex99-1_cormedix.htm EX-99.1 17360
3 GRAPHIC ex99-1_001.jpg GRAPHIC 10463
  Complete submission text file 0001213900-25-001392.txt   240728

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20250107.xsd EX-101.SCH 3015
5 XBRL LABEL FILE crmd-20250107_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE crmd-20250107_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0226957-8k_cormedix_htm.xml XML 3671
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 25513488
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)